Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 57.85M P/E - EPS this Y 29.30% Ern Qtrly Grth -
Income -51.35M Forward P/E -1.39 EPS next Y -1.50% 50D Avg Chg 3.00%
Sales 12.95M PEG -0.09 EPS past 5Y - 200D Avg Chg -11.00%
Dividend N/A Price/Book 0.82 EPS next 5Y 17.00% 52W High Chg -50.00%
Recommedations 2.50 Quick Ratio 2.92 Shares Outstanding 6.35M 52W Low Chg 44.00%
Insider Own 32.69% ROA -34.37% Shares Float 3.74M Beta 0.65
Inst Own 10.61% ROE -99.78% Shares Shorted/Prior 14.35K/16.08K Price 1.11
Gross Margin 104.26% Profit Margin - Avg. Volume 104,867 Target Price 36.00
Oper. Margin -185.46% Earnings Date Aug 7 Volume 75,741 Change 1.83%
About Assembly Biosciences, Inc.

Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases. It develops ABI-5366, a long-acting herpes simplex virus (HSV) helicase-primase inhibitor that is in Phase 1a/1b clinical trial to treat recurrent genital herpes; ABI-1179, which is in Phase 1a/1b clinical trial for the treatment of recurrent genital herpes; and ABI-6250, a small molecule orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical trial. The company also develops ABI-4334, a next-generation capsid assembly modulator, which is in Phase 1b clinical trial for the treatment of hepatitis B virus (HBV). In addition, it develops an oral non-nucleoside polymerase inhibitor targeting transplant-related herpesviruses; and a small molecule interferon-a receptor agonist targeting HBV and HDV. The company has collaboration agreements with Gilead Sciences, Inc. and BeiGene, Ltd. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.

Assembly Biosciences, Inc. News
07/19/24 Investors in Assembly Biosciences (NASDAQ:ASMB) have unfortunately lost 90% over the last five years
07/15/24 Assembly Biosciences Presents New Preclinical Data Highlighting Investigational Helicase-Primase Inhibitors at International Herpesvirus Workshop
06/18/24 Assembly Biosciences Doses First Participant in Phase 1b Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 for the Treatment of Chronic Hepatitis B Virus Infection
06/17/24 Assembly Biosciences Announces $12.6 Million in Equity Financings
06/10/24 Assembly Biosciences Doses First Participant in Phase 1a/b Clinical Trial of Herpes Simplex Virus Helicase-Primase Inhibitor Candidate ABI-5366
06/05/24 Assembly Biosciences Presents New Data Highlighting Hepatitis D Virus Entry Inhibitor ABI-6250 at the EASL Congress™ 2024
05/22/24 Assembly Biosciences to Present Data at Upcoming International Herpesvirus Workshop and EASL Congress™ 2024
05/16/24 Are Medical Stocks Lagging Entera Bio (ENTX) This Year?
05/08/24 Assembly Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights
04/09/24 Are Medical Stocks Lagging ASLAN Pharmaceuticals (ASLN) This Year?
03/28/24 Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights
02/08/24 Assembly Biosciences Announces Effective Date of Reverse Stock Split
01/15/24 This Assembly Biosciences Insider Increased Their Holding In The Last Year
01/04/24 Assembly Biosciences Provides Anticipated Development Milestones for 2024
11/10/23 Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
11/10/23 Assembly Biosciences Presents New Data Highlighting Viral Hepatitis Portfolio at AASLD The Liver Meeting®
11/08/23 Assembly Biosciences Reports Third Quarter 2023 Financial Results and Recent Updates
11/08/23 Assembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief Medical Officer
10/17/23 Gilead and Assembly Biosciences Establish Partnership to Develop Next-Generation Therapeutics for Serious Viral Diseases
10/11/23 Assembly Biosciences to Present New Data at AASLD The Liver Meeting®
ASMB Chatroom

User Image Haifischflosse Posted - 1 day ago

$ASMB Armistice Capital, for example, was also involved in Morpheusis. Everyone can check where the shares are. Managers from Gield are already on the board of ASMB.

User Image Haifischflosse Posted - 1 day ago

$ASMB A. Schornstein has also bought over 12% of the shares. All three together have over 40% of the shares. They know exactly why they are buying now. If the next data is good, Gild could make a takeover here. We are then talking about 50-100 dollars per share.

User Image Haifischflosse Posted - 2 days ago

$ASMB will have reasons why they are getting in The hedge fund Armistice Capital has purchased 634,500 Assembly shares at a price of US$15.46 each, which corresponds to the upper end of the last closing prices. Assembly's cooperation partner Gilead is also buying a further 179,500 shares, which means that the pharmaceutical giant's share in Assembly remains at 19.9%.

User Image BioMan122 Posted - 2 days ago

$ASMB is this stock still traded at the stock market

User Image Stronx Posted - 3 days ago

$ASMB next 💥 $RGC

User Image onemillion2012 Posted - 3 days ago

$ASMB it's wild and just crazy today 994 shares traded. Who are the lucky buyer's.. it's gone wild

User Image onemillion2012 Posted - 5 days ago

@BK217 only 45.000 shares. My biggest holding is $asmb I got 25.000 shares in that.

User Image SearchFor911 Posted - 1 week ago

$ASMB 3 years to CAM approval 🚀

User Image SearchFor911 Posted - 1 week ago

$ASMB all eyes on $ALGS KOL event. showing the path to CAM approvals?

User Image wonapenny Posted - 1 week ago

$ASMB interesting that ABI-1179 is 2x more potent against HSV than ABI-5366… https://investor.assemblybio.com/events-presentations

User Image BioMan122 Posted - 1 week ago

$ASMB i now do not want this to rise anymore…

User Image wonapenny Posted - 1 week ago

$ASMB really nice that it’s back above the $15 level after flushing out weak hands. Perfect place to hang out until big news.

User Image onemillion2012 Posted - 1 week ago

@Trendrebel sådan. Jeg købte de første I $3,70 Kig på $asmb de har en spændene pipeline og har Gilliard I ryggen. En spændene case med 500-1000 procent optur.

User Image ACInvestorBlog Posted - 1 week ago

$ASMB Assembly Biosciences Presents New Preclinical Data Highlighting Investigational Helicase-Primase Inhibitors at International Herpesvirus Workshop https://www.globenewswire.com/en/news-release/2024/07/15/2912985/16259/en/Assembly-Biosciences-Presents-New-Preclinical-Data-Highlighting-Investigational-Helicase-Primase-Inhibitors-at-International-Herpesvirus-Workshop.html

User Image Stock_Titan Posted - 1 week ago

$ASMB Assembly Biosciences Presents New Preclinical Data Highlighting Investigational Helicase-Primase Inhibitors at International Herpesvirus Workshop https://www.stocktitan.net/news/ASMB/assembly-biosciences-presents-new-preclinical-data-highlighting-sq3xsp0yau6w.html

User Image NoGainer1 Posted - 1 week ago

$ASMB dummies ;D

User Image NVDAMillionaire Posted - 2 weeks ago

$ASMB Assembly Biosciences, Inc. (NASDAQ:ASMB): Advancing a Diverse Pipeline of Innovative Antiviral Therapies http://beyondspx.com/2024/07/12/assembly-biosciences-inc-nasdaqasmb-advancing-a-diverse-pipeline-of-innovative-antiviral-therapies/

User Image SearchFor911 Posted - 2 weeks ago

$ASMB Monday 🥰

User Image ACInvestorBlog Posted - 2 weeks ago

$ASMB Insider buying https://www.sec.gov/Archives/edgar/data/1426800/000107997324001035/xslF345X05/ownership.xml

User Image SearchFor911 Posted - 2 weeks ago

$ASMB stop loss raid - made in Germany 😉 https://www.sec.gov/Archives/edgar/data/1426800/000107997324001035/xslF345X05/ownership.xml Triggered the stop losses on German stock exchanges which caused the little meltdown to add some cheap shares (my opinion).

User Image insiderbuyingselling Posted - 2 weeks ago

$ASMB new insider buying: 9000 shares. http://insiderbuyingselling.com/?t=ASMB

User Image EagleMan1 Posted - 2 weeks ago

$EYEN $CASI and $ASMB and $LEXX and $SBFM What is new and opportunity in $EYEN? 1 - Insider bought 1.5 million shares in July and paid 1 Million dollars 2 - Vanguard biggest institution in the world bought 5 million dollars for a call option 3 - First FDA MydCombi selling from April 2024, and they have a contract with Vision Source biggest Private Practice Optometrists in the USA and Canada. Vision Source multi a billion company. 4 - Second FDA's strongest eyedrop sales start the first of August and are expected to generate 15 to 40 per quarter. 5 - 8 or 9 August earnings call, and it should be good. 6 - MicroPine and MicroLine are unmet need eyedrops for children and the result is coming in Q4 2024.

User Image _StockTrader Posted - 3 weeks ago

Real-Time Stock Data $ASMB Price: N/A Volume: 14925 Market Cap: 82365368 PE Ratio: -1.3520832 Powered by: AITX

User Image BioMan122 Posted - 3 weeks ago

$ASMB maybe only a bull trap 😫

User Image wonapenny Posted - 3 weeks ago

$ASMB maybe whoever dumped is buying back in? 🧐

User Image SearchFor911 Posted - 3 weeks ago

$ASMB 🚀 soon

User Image davedtire Posted - 3 weeks ago

$ASMB stopped out of this at 13.20 yesterday. Owned it since pre split when gild increased their position . Cost was 12.30. I don’t get this one at all and someone is selling premkt last few days. Not that it takes much to drop it but don’t see any buying either. Maybe they want it cheaper to buy more or maybe not. Disappointing no interest since rev split to get price higher . GL

User Image GambitMentality Posted - 3 weeks ago

Today's EOD TOP #StockMarket LOSERS by % led by $SLP $ANVS $CHAA $FTLF and $ASMB to lead the TOP 5

User Image BioMan122 Posted - 3 weeks ago

$ASMB if you sell this stock it will lay on the streets like dogshit. nobody will pick it up because this stinks so much…

User Image wonapenny Posted - 3 weeks ago

$ASMB ugh this sucks. It’s weird there’s been two days of relatively heavy selling in pre-market. I get it if someone wants to exit their position, but why do it in pre-market when there’s no negative news? Either they feel they need to offload immediately due to imminent bad news, or they want to drive the price lower, maybe. Who knows. Wish this would end soon.

Analyst Ratings
HC Wainwright & Co. Neutral Jun 20, 24
HC Wainwright & Co. Neutral Jun 13, 24
HC Wainwright & Co. Neutral Apr 1, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Schornstein Alexander 10% Owner 10% Owner Jan 17 Buy 0.79 645,080 509,613 8,209,372 01/19/24
Okazaki Jason A CEO and President CEO and President Aug 02 Sell 1.0879 11,827 12,867 164,786 08/03/23
McHutchison John G Director Director May 22 Sell 1.04 25,972 27,011 169,160 05/24/23
Bjorkquist Jeanette M Principal Accounting.. Principal Accounting Officer May 22 Sell 1.04 274 285 27,532 05/24/23
Delaney William E IV Chief Scientific Off.. Chief Scientific Officer May 22 Sell 1.04 6,561 6,823 116,437 05/24/23
Okazaki Jason A CEO and President CEO and President May 22 Sell 1.04 6,561 6,823 126,613 05/24/23
McHutchison John G Director Director Mar 30 Sell 0.8232 14,883 12,252 177,632 03/31/23
Bjorkquist Jeanette M Principal Accounting.. Principal Accounting Officer Feb 16 Sell 0.82 774 635 23,806 03/31/23
Delaney William E IV Chief Scientific Off.. Chief Scientific Officer Mar 29 Sell 0.8232 3,421 2,816 85,498 03/31/23
McHutchison John G Chief Executive Offi.. Chief Executive Officer Aug 08 Sell 2.1277 12,314 26,200 192,515 08/10/22
Samar Michael P. Chief Financial Offi.. Chief Financial Officer Jul 25 Sell 2.2174 2,020 4,479 77,228 07/26/22
Delaney William E IV Chief Scientific Off.. Chief Scientific Officer May 31 Sell 1.9224 4,164 8,005 76,419 06/02/22
Samar Michael P. Chief Financial Offi.. Chief Financial Officer Mar 29 Sell 2.17 2,285 4,958 76,748 03/31/22
Stamm Luisa M Chief Medical Office.. Chief Medical Officer Mar 29 Sell 2.17 1,038 2,252 40,315 03/31/22
Delaney William E IV Chief Scientific Off.. Chief Scientific Officer Mar 29 Sell 2.17 1,038 2,252 78,083 03/31/22
Okazaki Jason A Chief Operating Offi.. Chief Operating Officer Mar 29 Sell 2.17 1,269 2,754 94,614 03/31/22
McHutchison John G CEO and President CEO and President Mar 29 Sell 2.17 4,614 10,012 204,829 03/31/22
Okazaki Jason A Chief Operating Offi.. Chief Operating Officer Mar 28 Sell 2.2445 4,617 10,363 64,633 03/29/22